![Glen MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glen MacDonald
Directeur Général chez
Leucadia Finance Partners, Inc.
Profil
Glen C.
MacDonald is currently the President, CEO, CFO & Director at Leucadia Finance Partners, Inc. He was previously the Chief Scientific Officer at Viventia Biotech, Inc. from 2005 to 2012 and again from 2012 to 2016.
He was also the Chief Scientific Officer at Sesen Bio, Inc. from 2016 to 2017.
Additionally, he held a position as Principal at Princess Margaret Hospital Foundation and The University of North Carolina at Charlotte.
Dr. MacDonald received his undergraduate degree from the University of Guelph in 1980, his graduate degree from the University of Manitoba in 1987, and his doctorate from the University of Manitoba in 1993.
Postes actifs de Glen MacDonald
| Sociétés | Poste | Début |
|---|---|---|
Leucadia Finance Partners, Inc.
 Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Directeur Général | - |
Anciens postes connus de Glen MacDonald
| Sociétés | Poste | Fin |
|---|---|---|
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Directeur Technique/Scientifique/R&D | 01/09/2016 |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Directeur Technique/Scientifique/R&D | 01/01/2012 |
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Glen MacDonald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Health Technology |
